EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

N‐Acetylglucosamine Selectively Attenuates Neuroinflammation in a Mouse Model of Mitochondrial Dysfunction

Laura Jiménez-Sánchez iD, Paula Ruiz-López, Pilar González-García, Janne Purhonen, Juan Manuel Martínez-Gálvez, Sergio López-Herrador, Julia Corral-Sarasa, María Elena Díaz-Casado, Carmen Venegas, Isaac Santos-Pérez, Enrica Olivieri, Adriana L Rojas iD und 1 weitere

Acta Physiologica · 2026-03 · 242 (3)

DOI: 10.1111/apha.70179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Physiologica, online erschienen am 17.02.2026. Verfasst von Laura Jiménez-Sánchez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación Biosanitaria ibs.Granada, Granada, Spain. Hauptthemen laut MEDLINE: Acetylglucosamine, Neuroinflammatory Diseases, Mitochondria, Mitochondrial Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministerio de Ciencia e Innovación, Consejería de Salud y Consumo, Junta de Andalucía, Ministerio de Universidades.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Mitochondrial dysfunction plays a central role in multiple neurodegenerative diseases, yet the temporal sequence of cellular events underlying neurodegeneration remains poorly defined. This study aimed to characterize the progression of neurodegeneration in a mouse model of fatal mitochondrial encephalopathy and to evaluate the therapeutic potential of oral N‐acetylglucosamine supplementation.

Methods

A mouse model of primary coenzyme Q deficiency was used to examine neurodegeneration at presymptomatic, symptomatic and terminal stages. Neuronal integrity, glial activation, myelination and inflammatory responses were assessed using histological, molecular and ultrastructural approaches, together with behavioral analysis of motor coordination. N acetylglucosamine was administered orally from 1 month of age, and its effects on neuroinflammation, myelin integrity and motor performance were evaluated.

Results

Astrocyte activation and neuronal loss were detected before the onset of clinical symptoms, whereas proinflammatory microglia appeared at later disease stages. Early myelin abnormalities were accompanied by an initial increase in oligodendrocyte precursor cells, suggesting a compensatory response to early myelin stress. Oral N‐acetylglucosamine supplementation reduced glial activation and neuroinflammatory markers, likely through modulation of inflammatory signaling pathways. Although treatment did not fully reverse structural damage or restore myelin protein expression, it led to a significant improvement in motor coordination.

Conclusion

These findings define a temporal sequence of early glial activation, neuronal loss, and myelin alterations in mitochondrial encephalopathy. Targeting glial responses and neuroinflammation at early disease stages may mitigate neurodegenerative progression and improve functional outcomes, highlighting a physiologically relevant therapeutic window for mitochondrial disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetylglucosamineNeuroinflammatory DiseasesMitochondriaMitochondrial DiseasesAnimalsMiceDisease Models, AnimalMice, Inbred C57BLMale

Stichwörter der Autor:innen

N‐acetylglucosaminecoenzyme Qmitochondrianeuroinflammation

Substanzen

Acetylglucosamine

Autor:innen und Institutionen

  • Instituto de Investigación Biosanitaria ibs.Granada, Granada, Spain.
  • Departament of Physiology, Facultad de Medicina, Universidad de Granada, Granada, Spain.
  • Instituto de Biotecnología, Centro de Investigación Biomédica, Universidad de Granada, Granada, Spain.
  • Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.
  • Biofisika Institute (CSIC, UBV-EHU) and Department of Biochemistry and Molecular Biology, University of Basque Country, Leioa, Spain.
  • Electron Microscopy and Crystallography, Center for Cooperative Research in Biosciences (CIC bioGUNE), Bizkaia Science and Technology Park, Derio, Bizkaia, Spain.

ORCID-Profile: Laura Jiménez-Sánchez, Adriana L Rojas, Luis Carlos López

Förderung

  • Ministerio de Ciencia e Innovación
  • Consejería de Salud y Consumo, Junta de Andalucía
  • Ministerio de Universidades
  • Universidad de Granada
  • Consejería de Salud y Familias, Junta de Andalucía
  • Sigrid Jusélius Foundation
  • Ministerio de Ciencia, Innovación y Universidades
  • Sigrid Juséliuksen Säätiö

Zitieren

APA

Jiménez-Sánchez, L., Ruiz-López, P., González-García, P., Purhonen, J., Martínez-Gálvez, J. M., López-Herrador, S., Corral-Sarasa, J., Díaz-Casado, M. E., Venegas, C., Santos-Pérez, I., Olivieri, E., Rojas, A. L., & López, L. C. (2026). N‐Acetylglucosamine Selectively Attenuates Neuroinflammation in a Mouse Model of Mitochondrial Dysfunction. Acta Physiologica, 242(3). https://doi.org/10.1111/apha.70179

Vancouver

Jiménez-Sánchez L, Ruiz-López P, González-García P, Purhonen J, Martínez-Gálvez JM, López-Herrador S, et al. N‐Acetylglucosamine Selectively Attenuates Neuroinflammation in a Mouse Model of Mitochondrial Dysfunction. Acta Physiologica. 2026;242(3). doi:10.1111/apha.70179

BibTeX
@article{JimnezSnchez2026,
  author = {Jiménez-Sánchez, Laura and Ruiz-López, Paula and González-García, Pilar and Purhonen, Janne and Martínez-Gálvez, Juan Manuel and López-Herrador, Sergio and Corral-Sarasa, Julia and Díaz-Casado, María Elena and Venegas, Carmen and Santos-Pérez, Isaac and Olivieri, Enrica and Rojas, Adriana L and López, Luis Carlos},
  title = {N‐Acetylglucosamine Selectively Attenuates Neuroinflammation in a Mouse Model of Mitochondrial Dysfunction},
  journal = {Acta Physiologica},
  year = {2026},
  volume = {242},
  number = {3},
  doi = {10.1111/apha.70179}
}
Kostenlos starten →